http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-207477801-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2435ff25d50bdd835aa60471386f7db1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-04
filingDate 2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a3c0088f54159e658ebe2c5bbe2afad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c036ca297fe5309210164bc02f3198ff
publicationDate 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-207477801-U
titleOfInvention A kind of device using amplitude modulation electric field treatment tumour
abstract A kind of device using amplitude modulation electric field treatment tumour, including power supply, central control unit, FM signal generating unit, amplitude modulation unit, power amplification unit, output allocation unit, insulating electrode.Required frequency signal occurs for frequency modulation signal generating unit under central control unit control, required frequency signal generates required amplitude-modulated wave signal through amplitude modulation unit modulation, amplitude-modulated wave signal is assigned to more than one pair of insulating electrode after power amplification unit amplifies by output allocation unit, makes the amplitude modulation electric field of generation Strength Changes between a pair of more than insulating electrode.Amplitude modulation electric field is used to treat tumour as the uneven external electric field for being applied to focal zone, has the characteristics that ensure to make tumour cell by the electrical field stimulation of its sensitive intensity and harm that low-frequency current is avoided to be applied to human body.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110672711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113663215-A
priorityDate 2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451071287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561789
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID227728
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID227728
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56841936
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203623
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40848
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43359
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33501
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41124

Total number of triples: 33.